Perfluorohexyloctane

Unassigned

New Medicines

Dry eye syndrome (DES) associated with Meibomian gland dysfunction

Information

New molecular entity
Bausch Health Companies
Bausch Health Companies

Development and Regulatory status

Phase III Clinical Trials
Phase III Clinical Trials
Phase III Clinical Trials

Category

Ssuggested to mobilize thickened lipid in meibomian glands
Dry eye syndrome is common, affecting 15-33% of those aged over 65 years. Prevalence increases with age. It is 50% more common in women than in men [2].
Dry eye syndrome (DES) associated with Meibomian gland dysfunction
Intraocular